US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Neurosense Therapeutics Ltd

0.7700

0.0000

Post-market: 0.77000.00000.00%16:04 EDT

Volume:63.03K

Turnover:49.24K

Market Cap:25.72M

PE:-2.04

High:0.8100

Open:0.7700

Low:0.7700

Close:0.7700

52wk High:2.60

52wk Low:0.6300

Shares:33.40M

Float Shares:22.11M

Volume Ratio:0.28

T/O Rate:0.29%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.3778

EPS(LYR):-0.5489

ROE:-2478.16%

ROA:-303.90%

PB:-49.55

PE(LYR):-1.40

Loading ...

Overview Company News Filings

NeuroSense Therapeutics Granted U.S. Patent for Alzheimer's Disease Treatment, Extending Protection Through 2043

Press Release: World-Renowned Alzheimer's Expert Prof. Steven Arnold Joins NeuroSense SAB

Neurosense Confirms Favorable Safety and Tolerability of Primec in an Alzheimer's Phase 2 Study

THOMSON REUTERS

NeuroSense Reports PrimeC Shows Favorable Safety in Alzheimer's Phase 2 Trial

NeuroSense Therapeutics Locks Database for Phase 2 Alzheimer's Trial with Topline Results Expected in 2026

BRIEF-Neurosense Therapeutics Ltd - Resuming Regulatory Advancement In Canada For Primec In Amyotrophic Lateral Sclerosis

Neurosense Therapeutics Ltd - Resuming Regulatory Advancement in Canada for Primec in Amyotrophic Lateral Sclerosis

THOMSON REUTERS

Neurosense Therapeutics Ltd - Anticipates Potential Nds Submission by Mid-2026

THOMSON REUTERS

BUZZ-U.S. STOCKS ON THE MOVE-Morgan Stanley, Merck, Genco

BUZZ-NeuroSense rises after U.S. FDA clears late-stage ALS drug trial

Neurosense Receives FDA Clearance to Initiate Pivotal Phase 3 Trial for Primec in ALS

THOMSON REUTERS

FDA Clears NeuroSense Therapeutics to Launch Phase 3 Trial of PrimeC for ALS

NeuroSense Therapeutics Shareholders to Vote on Granting Restricted Shares to Non-Management Directors at Upcoming Meeting

NeuroSense Therapeutics to Host Investor Update Webinar

NeuroSense files to sell 333K ordinary shares for holders

Neurosense Therapeutics Ltd : Noble Capital Initiates Coverage With Outperform Rating; Target Price $9

THOMSON REUTERS

NeuroSense announces ‘positive’ results from Phase-2b PARADIGM study

Neurosense Therapeutics Ltd -Primec Produces Statistically Significant Reductions in Alzheimer’s Disease Biomarkers

THOMSON REUTERS

NeuroSense Therapeutics Announces Positive Phase 2b Results for PrimeC, Showing Significant Reduction in Alzheimer’s Disease Biomarkers

NeuroSense Therapeutics Ltd. Held Annual General Meeting of Shareholders

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/NRSN/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NRSN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NRSN\",,,,,undefined,":{"symbol":"NRSN","market":"US","secType":"STK","nameCN":"Neurosense Therapeutics Ltd","latestPrice":0.77,"timestamp":1774555200000,"preClose":0.77,"halted":0,"volume":63028,"hourTrading":{"tag":"盘后","latestPrice":0.77,"preClose":0.77,"latestTime":"16:04 EDT","volume":148,"amount":113.96000000000001,"timestamp":1774555484833,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0,"floatShares":22107900,"shares":33396600,"eps":-0.377806,"marketStatus":"Post-Mkt","change":0,"latestTime":"03-26 17:59:40 EDT","open":0.77,"high":0.81,"low":0.77,"amount":49242.923331,"amplitude":0.051948,"askPrice":0.7896,"askSize":100,"bidPrice":0.76,"bidSize":20,"shortable":3,"etf":0,"ttmEps":-0.377806,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1774569600000},"marketStatusCode":4,"adr":0,"listingDate":1639026000000,"exchange":"NASDAQ","adjPreClose":0.77,"preHourTrading":{"tag":"盘前","latestPrice":0.8099,"preClose":0.77,"latestTime":"09:22 EDT","volume":457,"amount":362.95030029000003,"timestamp":1774531334862,"change":0.0399,"changeRate":0.051818,"amplitude":0.051818},"postHourTrading":{"tag":"盘后","latestPrice":0.77,"preClose":0.77,"latestTime":"16:04 EDT","volume":148,"amount":113.96000000000001,"timestamp":1774555484833,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.281585},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NRSN\",,,,,undefined,":{"symbol":"NRSN","floatShares":22107900,"roa":"-303.90%","roe":"-2478.16%","lyrEps":-0.548863,"volumeRatio":0.281585,"shares":33396600,"dividePrice":0,"high":0.81,"amplitude":0.051948,"preClose":0.77,"low":0.77,"week52Low":0.63,"pbRate":"-49.55","week52High":2.6,"institutionHeld":0,"latestPrice":0.77,"committee":-0.666667,"eps":-0.377806,"divideRate":0,"volume":63028,"delay":0,"ttmEps":-0.377806,"open":0.77,"prevYearClose":0.769,"prevWeekClose":0.753,"prevMonthClose":0.9089,"prevQuarterClose":0.769,"fiveDayClose":0.7887,"twentyDayClose":0.9018,"sixtyDayClose":0.76},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NRSN\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-08-01","symbol":"NRSN","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1754020800000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2025-04-07","symbol":"NRSN","fiscalQuarterEnding":"2024/12","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1743998400000,"reportTimeType":"post","actualEps":-0.06},{"market":"US","date":"2024-12-18","symbol":"NRSN","fiscalQuarterEnding":"2024/09","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1734498000000,"reportTimeType":"pre","actualEps":-0.11},{"market":"US","date":"2024-06-24","symbol":"NRSN","fiscalQuarterEnding":"2024/03","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1719201600000,"reportTimeType":"pre","actualEps":-0.35},{"market":"US","date":"2024-04-05","symbol":"NRSN","fiscalQuarterEnding":"2023/12","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1712289600000,"reportTimeType":"pre","actualEps":-0.16}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NRSN\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NRSN\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":4,"updateTime":1773201600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/NRSN\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"NRSN","date":"2026-03-25","current":-2.039936,"percent":0.381086,"low":-12.966568,"twenty":-3.63758,"median":-2.349527,"eighty":-1.547595,"high":-0.395084,"avg":-2.737397,"sd":1.612538,"marketCap":24379523},"quantilePoints":[{"date":"2021-12-10","current":-6.574093,"twenty":-10.190888,"median":-8.533367,"eighty":-7.593999,"marketCap":34566580},{"date":"2021-12-17","current":-6.369292,"twenty":-8.481481,"median":-7.033255,"eighty":-6.696973,"marketCap":33489739},{"date":"2021-12-23","current":-6.010892,"twenty":-7.839759,"median":-6.778893,"eighty":-6.385676,"marketCap":31605268},{"date":"2021-12-31","current":-5.03809,"twenty":-7.126398,"median":-6.420492,"eighty":-5.387602,"marketCap":26490276},{"date":"2022-01-07","current":-5.24289,"twenty":-6.939702,"median":-6.041612,"eighty":-5.268367,"marketCap":27567116},{"date":"2022-01-14","current":-5.632011,"twenty":-6.791181,"median":-5.652491,"eighty":-5.268367,"marketCap":29613113},{"date":"2022-01-21","current":-4.812809,"twenty":-6.737933,"median":-5.611531,"eighty":-5.166254,"marketCap":25305751},{"date":"2022-01-28","current":-3.829767,"twenty":-6.545421,"median":-5.509131,"eighty":-4.931594,"marketCap":20136917},{"date":"2022-02-04","current":-3.725547,"twenty":-6.426636,"median":-5.37601,"eighty":-4.251656,"marketCap":19588925},{"date":"2022-02-11","current":-3.663107,"twenty":-6.40206,"median":-5.24289,"eighty":-3.929516,"marketCap":19260619},{"date":"2022-02-18","current":-3.267658,"twenty":-6.303756,"median":-5.10977,"eighty":-3.725547,"marketCap":17181348},{"date":"2022-02-25","current":-3.14278,"twenty":-6.041612,"median":-5.01761,"eighty":-3.663107,"marketCap":16524736},{"date":"2022-03-04","current":-3.954491,"twenty":-6.010892,"median":-4.91521,"eighty":-3.683921,"marketCap":20792714},{"date":"2022-03-11","current":-2.934649,"twenty":-5.672971,"median":-4.706253,"eighty":-3.645447,"marketCap":15430382},{"date":"2022-03-18","current":-3.246845,"twenty":-5.652491,"median":-4.464649,"eighty":-3.267658,"marketCap":17071913},{"date":"2022-03-25","current":-8.783133,"twenty":-6.369292,"median":-4.706253,"eighty":-3.352784,"marketCap":46181713},{"date":"2022-04-01","current":-7.804917,"twenty":-6.778893,"median":-4.91521,"eighty":-3.579855,"marketCap":41038252},{"date":"2022-04-08","current":-5.89011,"twenty":-7.033255,"median":-5.04833,"eighty":-3.621481,"marketCap":30970201},{"date":"2022-04-14","current":-5.470413,"twenty":-6.846149,"median":-5.01761,"eighty":-3.640654,"marketCap":22105938},{"date":"2022-04-22","current":-6.4995,"twenty":-6.782989,"median":-5.16097,"eighty":-3.659575,"marketCap":26264481},{"date":"2022-04-29","current":-4.54965,"twenty":-6.615053,"median":-5.207035,"eighty":-3.663107,"marketCap":18385137},{"date":"2022-05-06","current":-4.197594,"twenty":-6.514419,"median":-5.05857,"eighty":-3.663107,"marketCap":16962477},{"date":"2022-05-13","current":-3.439319,"twenty":-6.444486,"median":-4.985732,"eighty":-3.653865,"marketCap":13898288},{"date":"2022-05-20","current":-4.073327,"twenty":-6.414348,"median":-4.894729,"eighty":-3.613156,"marketCap":16460316},{"date":"2022-05-27","current":-4.304438,"twenty":-6.377484,"median":-4.641324,"eighty":-3.640654,"marketCap":17394234},{"date":"2022-06-03","current":-3.629217,"twenty":-6.349925,"median":-4.548658,"eighty":-3.579438,"marketCap":16810535},{"date":"2022-06-10","current":-3.679623,"twenty":-6.207023,"median":-4.495488,"eighty":-3.604831,"marketCap":17044015},{"date":"2022-06-17","current":-4.183681,"twenty":-6.073112,"median":-4.437259,"eighty":-3.626123,"marketCap":19378811},{"date":"2022-06-24","current":-4.284493,"twenty":-6.029324,"median":-4.307067,"eighty":-3.635709,"marketCap":19845771},{"date":"2022-07-01","current":-8.316957,"twenty":-6.35638,"median":-4.441325,"eighty":-3.649036,"marketCap":38524143},{"date":"2022-07-08","current":-6.754377,"twenty":-6.429933,"median":-4.495488,"eighty":-3.65473,"marketCap":31286274},{"date":"2022-07-15","current":-5.191797,"twenty":-6.429933,"median":-4.548658,"eighty":-3.657397,"marketCap":24048404},{"date":"2022-07-22","current":-4.61213,"twenty":-6.423442,"median":-4.61213,"eighty":-3.663107,"marketCap":21363388},{"date":"2022-07-29","current":-4.712942,"twenty":-6.40206,"median":-4.762875,"eighty":-3.663107,"marketCap":21830348},{"date":"2022-08-05","current":-4.788551,"twenty":-6.362836,"median":-4.788551,"eighty":-3.66641,"marketCap":22180567},{"date":"2022-08-12","current":-5.368217,"twenty":-6.329755,"median":-4.80068,"eighty":-3.680483,"marketCap":24865583},{"date":"2022-08-19","current":-4.939768,"twenty":-6.265441,"median":-4.838957,"eighty":-3.683921,"marketCap":22881006},{"date":"2022-08-26","current":-5.04058,"twenty":-6.123516,"median":-4.892046,"eighty":-3.688102,"marketCap":23347966},{"date":"2022-09-02","current":-3.184552,"twenty":-6.104613,"median":-4.889362,"eighty":-3.680483,"marketCap":22881006},{"date":"2022-09-09","current":-3.265791,"twenty":-6.041612,"median":-4.838957,"eighty":-3.663107,"marketCap":23464705},{"date":"2022-09-16","current":-3.2008,"twenty":-6.023493,"median":-4.80068,"eighty":-3.629217,"marketCap":22997746},{"date":"2022-09-23","current":-2.599634,"twenty":-6.010892,"median":-4.738145,"eighty":-3.553609,"marketCap":18678372},{"date":"2022-09-30","current":-2.908341,"twenty":-5.930794,"median":-4.697946,"eighty":-3.4664,"marketCap":20896429},{"date":"2022-10-07","current":-2.745864,"twenty":-5.89011,"median":-4.61213,"eighty":-3.363277,"marketCap":19729031},{"date":"2022-10-14","current":-2.778359,"twenty":-5.822469,"median":-4.548658,"eighty":-3.298286,"marketCap":19962510},{"date":"2022-10-21","current":-2.518396,"twenty":-5.795388,"median":-4.495488,"eighty":-3.249543,"marketCap":18094673},{"date":"2022-10-28","current":-2.469653,"twenty":-5.741225,"median":-4.437259,"eighty":-3.184552,"marketCap":17744454},{"date":"2022-11-04","current":-2.420909,"twenty":-5.723606,"median":-4.304438,"eighty":-3.168304,"marketCap":17394234},{"date":"2022-11-11","current":-2.453405,"twenty":-5.672971,"median":-4.278838,"eighty":-3.11156,"marketCap":17627714},{"date":"2022-11-18","current":-3.005177,"twenty":-5.670652,"median":-4.198408,"eighty":-3.038323,"marketCap":21592198},{"date":"2022-11-25","current":-2.84335,"twenty":-5.656123,"median":-4.197594,"eighty":-2.986918,"marketCap":20429470},{"date":"2022-12-02","current":-2.117174,"twenty":-5.636107,"median":-4.157963,"eighty":-2.932864,"marketCap":19670661},{"date":"2022-12-09","current":-1.985243,"twenty":-5.599243,"median":-4.108073,"eighty":-2.912736,"marketCap":18444893},{"date":"2022-12-16","current":-1.758322,"twenty":-5.574667,"median":-4.076348,"eighty":-2.875845,"marketCap":16336571},{"date":"2022-12-23","current":-1.633428,"twenty":-5.521419,"median":-3.954491,"eighty":-2.820603,"marketCap":15176177},{"date":"2022-12-30","current":-1.532909,"twenty":-5.4859,"median":-3.928883,"eighty":-2.778359,"marketCap":14242259},{"date":"2023-01-06","current":-1.584048,"twenty":-5.469859,"median":-3.892052,"eighty":-2.752363,"marketCap":14717390},{"date":"2023-01-13","current":-1.696252,"twenty":-5.468686,"median":-3.836529,"eighty":-2.70362,"marketCap":15759877},{"date":"2023-01-20","current":-2.257227,"twenty":-5.456819,"median":-3.807103,"eighty":-2.664625,"marketCap":20971894},{"date":"2023-01-27","current":-2.143097,"twenty":-5.410473,"median":-3.730029,"eighty":-2.632,"marketCap":19911517},{"date":"2023-02-03","current":-2.067011,"twenty":-5.399028,"median":-3.715187,"eighty":-2.586636,"marketCap":19204599},{"date":"2023-02-10","current":-2.117735,"twenty":-5.363632,"median":-3.683921,"eighty":-2.56064,"marketCap":19675878},{"date":"2023-02-17","current":-2.472805,"twenty":-5.337817,"median":-3.663107,"eighty":-2.498898,"marketCap":22974827},{"date":"2023-02-24","current":-2.586934,"twenty":-5.307925,"median":-3.659538,"eighty":-2.469653,"marketCap":24035204},{"date":"2023-03-03","current":-2.181267,"twenty":-5.306583,"median":-3.645447,"eighty":-2.421072,"marketCap":20266154},{"date":"2023-03-10","current":-2.168459,"twenty":-5.292609,"median":-3.600668,"eighty":-2.384037,"marketCap":20147156},{"date":"2023-03-17","current":-2.29527,"twenty":-5.24289,"median":-3.553609,"eighty":-2.307663,"marketCap":21325353},{"date":"2023-03-24","current":-1.662583,"twenty":-5.226682,"median":-3.507022,"eighty":-2.269908,"marketCap":20516275},{"date":"2023-03-31","current":-1.643473,"twenty":-5.217,"median":-3.439319,"eighty":-2.231865,"marketCap":20280456},{"date":"2023-04-06","current":-1.624363,"twenty":-5.196838,"median":-3.395772,"eighty":-2.206503,"marketCap":20044637},{"date":"2023-04-14","current":-1.595698,"twenty":-5.188271,"median":-3.35543,"eighty":-2.181242,"marketCap":19690908},{"date":"2023-04-21","current":-1.834574,"twenty":-5.170753,"median":-3.298286,"eighty":-2.165923,"marketCap":22638648},{"date":"2023-04-28","current":-1.815464,"twenty":-5.162095,"median":-3.266725,"eighty":-2.132364,"marketCap":22402829},{"date":"2023-05-05","current":-1.663852,"twenty":-5.104983,"median":-3.246845,"eighty":-2.105764,"marketCap":20531935},{"date":"2023-05-12","current":-1.663852,"twenty":-5.090986,"median":-3.192676,"eighty":-2.067939,"marketCap":20531935},{"date":"2023-05-19","current":-1.635165,"twenty":-5.090986,"median":-3.184406,"eighty":-2.021262,"marketCap":20177936},{"date":"2023-05-26","current":-1.577791,"twenty":-5.070824,"median":-3.160181,"eighty":-1.98273,"marketCap":19469938},{"date":"2023-05-30","current":-1.529979,"twenty":-5.065783,"median":-3.152057,"eighty":-1.972678,"marketCap":18879940},{"date":"2023-06-09","current":-1.667747,"twenty":-5.05857,"median":-3.123684,"eighty":-1.940201,"marketCap":22537929},{"date":"2023-06-16","current":-1.606625,"twenty":-5.04058,"median":-3.08034,"eighty":-1.922419,"marketCap":21711931},{"date":"2023-06-23","current":-1.397065,"twenty":-5.04058,"median":-3.038323,"eighty":-1.882,"marketCap":18879940},{"date":"2023-06-30","current":-1.257359,"twenty":-5.04058,"median":-2.989579,"eighty":-1.815464,"marketCap":16991946},{"date":"2023-07-07","current":-1.340783,"twenty":-5.039584,"median":-2.976275,"eighty":-1.751128,"marketCap":18119348},{"date":"2023-07-14","current":-1.331068,"twenty":-5.029005,"median":-2.934649,"eighty":-1.709433,"marketCap":17988049},{"date":"2023-07-21","current":-1.388002,"twenty":-5.015377,"median":-2.924589,"eighty":-1.68025,"marketCap":18757465},{"date":"2023-07-28","current":-1.32057,"twenty":-5.008078,"median":-2.911088,"eighty":-1.663852,"marketCap":17846185},{"date":"2023-08-04","current":-1.02823,"twenty":-4.994348,"median":-2.893022,"eighty":-1.662583,"marketCap":13895502},{"date":"2023-08-11","current":-1.018149,"twenty":-4.983838,"median":-2.859598,"eighty":-1.65429,"marketCap":13759272},{"date":"2023-08-18","current":-0.785704,"twenty":-4.970589,"median":-2.827102,"eighty":-1.643975,"marketCap":11988276},{"date":"2023-08-25","current":-0.803651,"twenty":-4.964971,"median":-2.794607,"eighty":-1.64232,"marketCap":12262100},{"date":"2023-09-01","current":-0.839275,"twenty":-4.95489,"median":-2.778359,"eighty":-1.635165,"marketCap":12805659},{"date":"2023-09-08","current":-0.832936,"twenty":-4.939768,"median":-2.762111,"eighty":-1.633428,"marketCap":12708935},{"date":"2023-09-15","current":-0.76508,"twenty":-4.939768,"median":-2.737821,"eighty":-1.624363,"marketCap":11673584},{"date":"2023-09-22","current":-0.785526,"twenty":-4.939768,"median":-2.697121,"eighty":-1.608262,"marketCap":11985552},{"date":"2023-09-29","current":-0.669634,"twenty":-4.934856,"median":-2.664625,"eighty":-1.59597,"marketCap":10217281},{"date":"2023-10-06","current":-0.521511,"twenty":-4.911114,"median":-2.63213,"eighty":-1.584467,"marketCap":7957218},{"date":"2023-10-13","current":-0.508922,"twenty":-4.893656,"median":-2.599634,"eighty":-1.571801,"marketCap":7765133},{"date":"2023-10-20","current":-0.482315,"twenty":-4.889362,"median":-2.586934,"eighty":-1.557715,"marketCap":7359167},{"date":"2023-10-27","current":-0.420977,"twenty":-4.889362,"median":-2.583386,"eighty":-1.550731,"marketCap":6423264},{"date":"2023-11-03","current":-0.427673,"twenty":-4.859119,"median":-2.575182,"eighty":-1.529941,"marketCap":6525437},{"date":"2023-11-10","current":-0.473207,"twenty":-4.838957,"median":-2.534643,"eighty":-1.428226,"marketCap":7220198},{"date":"2023-11-17","current":-0.458923,"twenty":-4.823268,"median":-2.50621,"eighty":-1.39344,"marketCap":7002243},{"date":"2023-11-24","current":-0.573296,"twenty":-4.803106,"median":-2.471229,"eighty":-1.365256,"marketCap":8747355},{"date":"2023-12-01","current":-1.530812,"twenty":-4.788551,"median":-2.434888,"eighty":-1.354573,"marketCap":17573724},{"date":"2023-12-08","current":-0.947576,"twenty":-4.768389,"median":-2.421072,"eighty":-1.344766,"marketCap":10878169},{"date":"2023-12-15","current":-1.035548,"twenty":-4.728064,"median":-2.409536,"eighty":-1.33788,"marketCap":11888089},{"date":"2023-12-22","current":-0.924958,"twenty":-4.712942,"median":-2.352334,"eighty":-1.320883,"marketCap":10618514},{"date":"2023-12-29","current":-0.928529,"twenty":-4.712942,"median":-2.34536,"eighty":-1.310489,"marketCap":10659512},{"date":"2024-01-05","current":-0.929719,"twenty":-4.694947,"median":-2.307807,"eighty":-1.276215,"marketCap":10673178},{"date":"2024-01-12","current":-1.105068,"twenty":-4.65558,"median":-2.29527,"eighty":-1.218395,"marketCap":12686186},{"date":"2024-01-19","current":-1.130782,"twenty":-4.627252,"median":-2.269908,"eighty":-1.115354,"marketCap":12981373},{"date":"2024-01-26","current":-1.226134,"twenty":-4.607157,"median":-2.231865,"eighty":-1.134639,"marketCap":14076023},{"date":"2024-02-02","current":-1.541596,"twenty":-4.579679,"median":-2.219184,"eighty":-1.141376,"marketCap":17697524},{"date":"2024-02-09","current":-1.571357,"twenty":-4.548856,"median":-2.206503,"eighty":-1.166661,"marketCap":18039175},{"date":"2024-02-16","current":-1.583261,"twenty":-4.543502,"median":-2.181267,"eighty":-1.20534,"marketCap":18175835},{"date":"2024-02-23","current":-1.499931,"twenty":-4.528904,"median":-2.18114,"eighty":-1.210592,"marketCap":17219212},{"date":"2024-03-01","current":-2.107047,"twenty":-4.48932,"median":-2.162119,"eighty":-1.21423,"marketCap":24188894},{"date":"2024-03-08","current":-2.392748,"twenty":-4.459984,"median":-2.18114,"eighty":-1.214653,"marketCap":27468744},{"date":"2024-03-15","current":-1.654686,"twenty":-4.439699,"median":-2.162119,"eighty":-1.217027,"marketCap":18995798},{"date":"2024-03-22","current":-2.154663,"twenty":-4.408494,"median":-2.143097,"eighty":-1.221037,"marketCap":24735536},{"date":"2024-03-28","current":-2.05943,"twenty":-4.309696,"median":-2.142759,"eighty":-1.226134,"marketCap":23642252},{"date":"2024-04-05","current":-2.452269,"twenty":-4.304438,"median":-2.155221,"eighty":-1.239925,"marketCap":28152046},{"date":"2024-04-12","current":-2.323708,"twenty":-4.284493,"median":-2.154663,"eighty":-1.257359,"marketCap":26211430},{"date":"2024-04-19","current":-2.102403,"twenty":-4.278838,"median":-2.155221,"eighty":-1.270167,"marketCap":23715103},{"date":"2024-04-26","current":-1.936249,"twenty":-4.278838,"median":-2.143097,"eighty":-1.279703,"marketCap":21840892},{"date":"2024-05-03","current":-1.951616,"twenty":-4.234087,"median":-2.139758,"eighty":-1.280247,"marketCap":22014233},{"date":"2024-05-10","current":-1.803785,"twenty":-4.198408,"median":-2.130855,"eighty":-1.285655,"marketCap":20346698},{"date":"2024-05-17","current":-1.874781,"twenty":-4.197795,"median":-2.117455,"eighty":-1.309749,"marketCap":21147531},{"date":"2024-05-24","current":-1.789876,"twenty":-4.197594,"median":-2.10806,"eighty":-1.310489,"marketCap":20189806},{"date":"2024-05-31","current":-1.927374,"twenty":-4.186464,"median":-2.105942,"eighty":-1.311407,"marketCap":19479966},{"date":"2024-06-07","current":-1.963066,"twenty":-4.163519,"median":-2.103728,"eighty":-1.318783,"marketCap":19840706},{"date":"2024-06-14","current":-1.731067,"twenty":-4.157654,"median":-2.092373,"eighty":-1.321196,"marketCap":17495895},{"date":"2024-06-21","current":-1.602576,"twenty":-4.142944,"median":-2.087988,"eighty":-1.321352,"marketCap":16197231},{"date":"2024-06-28","current":-1.604945,"twenty":-4.118154,"median":-2.074553,"eighty":-1.316996,"marketCap":20201446},{"date":"2024-07-05","current":-1.762574,"twenty":-4.104917,"median":-2.071187,"eighty":-1.320883,"marketCap":22185517},{"date":"2024-07-12","current":-1.447317,"twenty":-4.091858,"median":-2.059598,"eighty":-1.321352,"marketCap":18217376},{"date":"2024-07-19","current":-1.048373,"twenty":-4.076953,"median":-2.053627,"eighty":-1.310948,"marketCap":13195873},{"date":"2024-07-26","current":-1.159807,"twenty":-4.038661,"median":-2.035308,"eighty":-1.279921,"marketCap":14598485},{"date":"2024-08-02","current":-1.057831,"twenty":-3.973793,"median":-2.024697,"eighty":-1.246899,"marketCap":13314917},{"date":"2024-08-09","current":-0.944338,"twenty":-3.945355,"median":-2.003606,"eighty":-1.217711,"marketCap":11886386},{"date":"2024-08-16","current":-1.191124,"twenty":-3.930544,"median":-1.990733,"eighty":-1.211681,"marketCap":14992674},{"date":"2024-08-23","current":-1.283939,"twenty":-3.928042,"median":-1.985243,"eighty":-1.211681,"marketCap":16160934},{"date":"2024-08-30","current":-1.376753,"twenty":-3.912889,"median":-1.981631,"eighty":-1.20534,"marketCap":17329195},{"date":"2024-09-06","current":-1.45611,"twenty":-3.887863,"median":-1.96912,"eighty":-1.209999,"marketCap":18328057},{"date":"2024-09-13","current":-2.088334,"twenty":-3.865327,"median":-1.965563,"eighty":-1.211473,"marketCap":26285858},{"date":"2024-09-20","current":-2.010988,"twenty":-3.839942,"median":-1.981631,"eighty":-1.212692,"marketCap":25312307},{"date":"2024-09-27","current":-1.98005,"twenty":-3.830626,"median":-1.98005,"eighty":-1.21423,"marketCap":24922887},{"date":"2024-10-04","current":-2.503926,"twenty":-3.820701,"median":-1.982351,"eighty":-1.214653,"marketCap":24533467},{"date":"2024-10-11","current":-2.245584,"twenty":-3.776823,"median":-1.988004,"eighty":-1.217027,"marketCap":22002236},{"date":"2024-10-18","current":-2.12635,"twenty":-3.743094,"median":-1.988004,"eighty":-1.219877,"marketCap":20833976},{"date":"2024-10-25","current":-2.523798,"twenty":-3.729133,"median":-1.995519,"eighty":-1.221492,"marketCap":24728177},{"date":"2024-11-01","current":-2.648772,"twenty":-3.725547,"median":-2.003739,"eighty":-1.228892,"marketCap":25952672},{"date":"2024-11-08","current":-2.690697,"twenty":-3.721403,"median":-2.016604,"eighty":-1.242231,"marketCap":26363451},{"date":"2024-11-15","current":-2.565548,"twenty":-3.700645,"median":-2.030063,"eighty":-1.251762,"marketCap":25137244},{"date":"2024-11-22","current":-1.902279,"twenty":-3.683921,"median":-2.03445,"eighty":-1.253603,"marketCap":18638532},{"date":"2024-11-29","current":-2.071582,"twenty":-3.683921,"median":-2.025676,"eighty":-1.256014,"marketCap":20297362},{"date":"2024-12-06","current":-2.198189,"twenty":-3.679623,"median":-2.039563,"eighty":-1.257359,"marketCap":21537860},{"date":"2024-12-13","current":-2.029841,"twenty":-3.663107,"median":-2.043819,"eighty":-1.258879,"marketCap":19888385},{"date":"2024-12-20","current":-2.712263,"twenty":-3.663107,"median":-2.059308,"eighty":-1.270167,"marketCap":31451400},{"date":"2024-12-27","current":-2.552718,"twenty":-3.663107,"median":-2.06238,"eighty":-1.277472,"marketCap":29601318},{"date":"2025-01-03","current":-2.37323,"twenty":-3.658824,"median":-2.067591,"eighty":-1.279541,"marketCap":27519975},{"date":"2025-01-10","current":-2.074083,"twenty":-3.655349,"median":-2.072223,"eighty":-1.279921,"marketCap":24051071},{"date":"2025-01-17","current":-2.183472,"twenty":-3.650831,"median":-2.071582,"eighty":-1.281724,"marketCap":25319545},{"date":"2025-01-24","current":-2.203504,"twenty":-3.642201,"median":-2.072865,"eighty":-1.284282,"marketCap":25551835},{"date":"2025-01-31","current":-2.223536,"twenty":-3.62767,"median":-2.074377,"eighty":-1.290474,"marketCap":25784124},{"date":"2025-02-07","current":-2.323695,"twenty":-3.613156,"median":-2.083313,"eighty":-1.309897,"marketCap":26945571},{"date":"2025-02-14","current":-2.313679,"twenty":-3.579646,"median":-2.084805,"eighty":-1.310718,"marketCap":26829426},{"date":"2025-02-21","current":-2.183472,"twenty":-3.578812,"median":-2.088161,"eighty":-1.311636,"marketCap":25319545},{"date":"2025-02-28","current":-2.218528,"twenty":-3.553609,"median":-2.088334,"eighty":-1.32057,"marketCap":25726052},{"date":"2025-03-07","current":-2.2636,"twenty":-3.528406,"median":-2.093757,"eighty":-1.321352,"marketCap":26248703},{"date":"2025-03-14","current":-2.363759,"twenty":-3.520563,"median":-2.103345,"eighty":-1.321352,"marketCap":27410150},{"date":"2025-03-21","current":-2.143409,"twenty":-3.493481,"median":-2.105444,"eighty":-1.324223,"marketCap":24854966},{"date":"2025-03-28","current":-1.99317,"twenty":-3.4664,"median":-2.105834,"eighty":-1.331068,"marketCap":23112796},{"date":"2025-04-04","current":-1.983154,"twenty":-3.439319,"median":-2.103345,"eighty":-1.332821,"marketCap":22996651},{"date":"2025-04-11","current":-2.490498,"twenty":-3.439319,"median":-2.105834,"eighty":-1.335944,"marketCap":25427989},{"date":"2025-04-17","current":-2.427766,"twenty":-3.404481,"median":-2.107047,"eighty":-1.339815,"marketCap":24787491},{"date":"2025-04-25","current":-2.349292,"twenty":-3.369776,"median":-2.116704,"eighty":-1.340783,"marketCap":23986270},{"date":"2025-05-02","current":-2.420013,"twenty":-3.359115,"median":-2.117735,"eighty":-1.340783,"marketCap":24708329},{"date":"2025-05-09","current":-2.452436,"twenty":-3.353842,"median":-2.128602,"eighty":-1.340912,"marketCap":25039372},{"date":"2025-05-16","current":-3.101375,"twenty":-3.335182,"median":-2.136757,"eighty":-1.348588,"marketCap":31665043},{"date":"2025-05-23","current":-3.430309,"twenty":-3.369776,"median":-2.142759,"eighty":-1.350749,"marketCap":35023456},{"date":"2025-05-30","current":-3.52429,"twenty":-3.433913,"median":-2.143253,"eighty":-1.356454,"marketCap":35983003},{"date":"2025-06-06","current":-4.041186,"twenty":-3.504314,"median":-2.143409,"eighty":-1.360215,"marketCap":41260510},{"date":"2025-06-13","current":-5.591874,"twenty":-3.538487,"median":-2.14431,"eighty":-1.361369,"marketCap":57093032},{"date":"2025-06-20","current":-5.756341,"twenty":-3.5758,"median":-2.155221,"eighty":-1.365256,"marketCap":58772239},{"date":"2025-06-27","current":-4.652063,"twenty":-3.626123,"median":-2.155917,"eighty":-1.37266,"marketCap":47497564},{"date":"2025-07-03","current":-4.487596,"twenty":-3.655659,"median":-2.166095,"eighty":-1.377613,"marketCap":45818357},{"date":"2025-07-11","current":-4.957502,"twenty":-3.67632,"median":-2.167308,"eighty":-1.382444,"marketCap":50616091},{"date":"2025-07-18","current":-4.628568,"twenty":-3.710767,"median":-2.173056,"eighty":-1.388401,"marketCap":47257677},{"date":"2025-07-25","current":-4.769539,"twenty":-3.743094,"median":-2.179806,"eighty":-1.391411,"marketCap":48696998},{"date":"2025-08-01","current":-4.229148,"twenty":-3.830626,"median":-2.18114,"eighty":-1.400575,"marketCap":43179604},{"date":"2025-08-08","current":-3.601902,"twenty":-3.829759,"median":-2.182797,"eighty":-1.414616,"marketCap":31185269},{"date":"2025-08-15","current":-3.324649,"twenty":-3.828495,"median":-2.183472,"eighty":-1.417338,"marketCap":28784813},{"date":"2025-08-22","current":-3.239402,"twenty":-3.815734,"median":-2.185967,"eighty":-1.428226,"marketCap":28046741},{"date":"2025-08-29","current":-3.239402,"twenty":-3.776823,"median":-2.193821,"eighty":-1.432044,"marketCap":28046741},{"date":"2025-09-05","current":-3.125739,"twenty":-3.74636,"median":-2.198189,"eighty":-1.447317,"marketCap":27062645},{"date":"2025-09-12","current":-3.267818,"twenty":-3.74636,"median":-2.203504,"eighty":-1.45611,"marketCap":28292765},{"date":"2025-09-19","current":-3.499934,"twenty":-3.730029,"median":-2.203504,"eighty":-1.461647,"marketCap":30302429},{"date":"2025-09-26","current":-3.413159,"twenty":-3.725547,"median":-2.206503,"eighty":-1.469568,"marketCap":29551129},{"date":"2025-10-03","current":-3.557784,"twenty":-3.725547,"median":-2.213056,"eighty":-1.475976,"marketCap":30803295},{"date":"2025-10-10","current":-3.615634,"twenty":-3.71273,"median":-2.22136,"eighty":-1.488027,"marketCap":31304162},{"date":"2025-10-17","current":-3.528859,"twenty":-3.712252,"median":-2.22944,"eighty":-1.488027,"marketCap":30552862},{"date":"2025-10-24","current":-3.355309,"twenty":-3.704826,"median":-2.231865,"eighty":-1.488027,"marketCap":29050262},{"date":"2025-10-31","current":-2.993745,"twenty":-3.683921,"median":-2.233628,"eighty":-1.499931,"marketCap":25919846},{"date":"2025-11-07","current":-2.978993,"twenty":-3.683921,"median":-2.244576,"eighty":-1.499931,"marketCap":25792125},{"date":"2025-11-14","current":-2.653904,"twenty":-3.679623,"median":-2.261599,"eighty":-1.500506,"marketCap":22977505},{"date":"2025-11-21","current":-3.094983,"twenty":-3.673485,"median":-2.2636,"eighty":-1.507779,"marketCap":26796363},{"date":"2025-11-28","current":-3.442084,"twenty":-3.665183,"median":-2.2636,"eighty":-1.511025,"marketCap":29801562},{"date":"2025-12-05","current":-3.471009,"twenty":-3.663107,"median":-2.269908,"eighty":-1.5149,"marketCap":30051996},{"date":"2025-12-12","current":-2.574332,"twenty":-3.663107,"median":-2.279041,"eighty":-1.517364,"marketCap":22288563},{"date":"2025-12-19","current":-2.36665,"twenty":-3.657397,"median":-2.285329,"eighty":-1.52255,"marketCap":20490452},{"date":"2025-12-26","current":-2.364625,"twenty":-3.65504,"median":-2.293458,"eighty":-1.52374,"marketCap":20472922},{"date":"2026-01-02","current":-2.224338,"twenty":-3.650831,"median":-2.285329,"eighty":-1.52374,"marketCap":19258320},{"date":"2026-01-09","current":-3.217598,"twenty":-3.645092,"median":-2.29527,"eighty":-1.525769,"marketCap":27857961},{"date":"2026-01-16","current":-3.397687,"twenty":-3.655349,"median":-2.299508,"eighty":-1.52924,"marketCap":29417175},{"date":"2026-01-23","current":-3.224801,"twenty":-3.652625,"median":-2.303063,"eighty":-1.529902,"marketCap":27920329},{"date":"2026-01-30","current":-3.632927,"twenty":-3.645269,"median":-2.305663,"eighty":-1.530146,"marketCap":31453885},{"date":"2026-02-06","current":-3.327347,"twenty":-3.642233,"median":-2.313679,"eighty":-1.530812,"marketCap":28808169},{"date":"2026-02-13","current":-3.824537,"twenty":-3.655659,"median":-2.318372,"eighty":-1.531231,"marketCap":33112839},{"date":"2026-02-20","current":-3.395977,"twenty":-3.663107,"median":-2.321244,"eighty":-1.532909,"marketCap":29402373},{"date":"2026-02-27","current":-3.478524,"twenty":-3.655969,"median":-2.323708,"eighty":-1.541596,"marketCap":30117061},{"date":"2026-03-06","current":-3.294916,"twenty":-3.65442,"median":-2.343329,"eighty":-1.545474,"marketCap":28527382},{"date":"2026-03-13","current":-3.278715,"twenty":-3.645447,"median":-2.34536,"eighty":-1.545474,"marketCap":28387116},{"date":"2026-03-20","current":-3.042262,"twenty":-3.644559,"median":-2.34941,"eighty":-1.547548,"marketCap":26339904},{"date":"2026-03-25","current":-2.815838,"twenty":-3.63758,"median":-2.349527,"eighty":-1.547595,"marketCap":24379523}],"updateTime":1774550243006},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NRSN\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2605728107","title":"NeuroSense Therapeutics Granted U.S. Patent for Alzheimer's Disease Treatment, Extending Protection Through 2043","url":"https://stock-news.laohu8.com/highlight/detail?id=2605728107","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605728107?lang=en_us&edition=fundamental","pubTime":"2026-01-21 21:31","pubTimestamp":1769002264,"startTime":"0","endTime":"0","summary":"NeuroSense Therapeutics Ltd. has been granted U.S. Patent No. 12,527,768 for compositions comprising an anti-inflammatory drug and a Dicer activator for use in the treatment of neuronal diseases, specifically Alzheimer's disease. The patent provides protection for the PrimeC combination therapy through 2043. The company's recent proof-of-concept study for Alzheimer's disease demonstrated a favorable safety and tolerability profile, with clinical and biomarker outcomes expected in the first quarter of 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Neurosense Therapeutics Ltd. published the original content used to generate this news brief via PR Newswire  on January 21, 2026, and is solely responsible for the information contained","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260121:nNDL5ccDX7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NRSN","BK4139"],"gpt_icon":0},{"id":"2601678053","title":"Press Release: World-Renowned Alzheimer's Expert Prof. Steven Arnold Joins NeuroSense SAB","url":"https://stock-news.laohu8.com/highlight/detail?id=2601678053","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601678053?lang=en_us&edition=fundamental","pubTime":"2026-01-08 21:45","pubTimestamp":1767879900,"startTime":"0","endTime":"0","summary":"Alzheimer's Clinical and Biomarker Outcomes Expected in Q1 2026. CAMBRIDGE, Mass., Jan. 8, 2026 /PRNewswire/ -- NeuroSense Therapeutics Ltd.  , a late-clinical stage biotechnology company developing novel treatments for severe neurodegenerative diseases, today announced that Prof. Steven E. Arnold, a world-renowned Alzheimer's disease expert and Professor of Neurology at Harvard Medical School, has joined the Company's Scientific Advisory Board. Prof. Arnold brings decades of experience in neurodegenerative disease research, biomarker-driven clinical development, and translational neuroscience, further strengthening NeuroSense's scientific leadership as it advances PrimeC in ALS and expands its Alzheimer's disease program.\"Prof. Arnold's depth of experience in biomarker-driven clinical development and translational neuroscience aligns closely with how we are advancing our programs,\" said Alon Ben-Noon, Co-Founder and Chief Executive Officer of NeuroSense. \"His perspective will be valua","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4132","BK4139","AD","NRSN"],"gpt_icon":0},{"id":"2593943361","title":"Neurosense Confirms Favorable Safety and Tolerability of Primec in an Alzheimer's Phase 2 Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2593943361","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593943361?lang=en_us&edition=fundamental","pubTime":"2025-12-22 22:19","pubTimestamp":1766413179,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251222:nFWN3XS0MZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","NRSN"],"gpt_icon":0},{"id":"2593433696","title":"NeuroSense Reports PrimeC Shows Favorable Safety in Alzheimer's Phase 2 Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2593433696","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593433696?lang=en_us&edition=fundamental","pubTime":"2025-12-22 22:18","pubTimestamp":1766413112,"startTime":"0","endTime":"0","summary":"NeuroSense Therapeutics Ltd. announced the completion of the safety analysis from its proof-of-concept Phase 2, randomized, double-blind, placebo-controlled study  evaluating PrimeC in Alzheimer's disease. The analysis indicated a favorable tolerability profile, with no serious adverse events or new safety signals reported. The company stated that clinical and biomarker outcome results are expected to be reported in the first quarter of 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Neurosense Therapeutics Ltd. published the original content used to generate this news brief via PR Newswire  on December 22, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251222:nNDL4HR3qd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NRSN","BK4139"],"gpt_icon":0},{"id":"2589353555","title":"NeuroSense Therapeutics Locks Database for Phase 2 Alzheimer's Trial with Topline Results Expected in 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2589353555","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589353555?lang=en_us&edition=fundamental","pubTime":"2025-12-08 21:01","pubTimestamp":1765198908,"startTime":"0","endTime":"0","summary":"NeuroSense Therapeutics Ltd. announced the completion of data collection for its Phase 2 proof-of-concept clinical trial of PrimeC in Alzheimer's disease, known as the RoAD study. The database for the study has been locked, confirming that all clinical data from the eight enrolled patients have been finalized for analysis. Topline results from the RoAD study are expected to be released in the first quarter of 2026. Additional details regarding the study and its timeline will be discussed during an investor webinar scheduled for December 8. Results have not yet been presented.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Neurosense Therapeutics Ltd. published the original content used to generate this news brief via EDGAR, the Electro","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251208:nNDL4vt9bt:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NRSN","BK4139"],"gpt_icon":0},{"id":"2588887882","title":"BRIEF-Neurosense Therapeutics Ltd - Resuming Regulatory Advancement In Canada For Primec In Amyotrophic Lateral Sclerosis","url":"https://stock-news.laohu8.com/highlight/detail?id=2588887882","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588887882?lang=en_us&edition=fundamental","pubTime":"2025-12-04 21:44","pubTimestamp":1764855879,"startTime":"0","endTime":"0","summary":"BRIEF-Neurosense Therapeutics Ltd - Resuming Regulatory Advancement In Canada For Primec In Amyotrophic Lateral SclerosisDec 4 (Reuters) - Neurosense Therapeutics Ltd NRSN.O:NEUROSENSE THERAPEUTICS LT","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251204:nFWN3XA104:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NRSN"],"gpt_icon":0},{"id":"2588882087","title":"Neurosense Therapeutics Ltd - Resuming Regulatory Advancement in Canada for Primec in Amyotrophic Lateral Sclerosis","url":"https://stock-news.laohu8.com/highlight/detail?id=2588882087","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588882087?lang=en_us&edition=fundamental","pubTime":"2025-12-04 21:40","pubTimestamp":1764855625,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251204:nFWN3XA104:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NRSN","BK4139"],"gpt_icon":0},{"id":"2588820698","title":"Neurosense Therapeutics Ltd - Anticipates Potential Nds Submission by Mid-2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2588820698","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588820698?lang=en_us&edition=fundamental","pubTime":"2025-12-04 21:40","pubTimestamp":1764855625,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251204:nFWN3XA104:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NRSN","BK4139"],"gpt_icon":0},{"id":"2585149573","title":"BUZZ-U.S. STOCKS ON THE MOVE-Morgan Stanley, Merck, Genco","url":"https://stock-news.laohu8.com/highlight/detail?id=2585149573","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585149573?lang=en_us&edition=fundamental","pubTime":"2025-11-24 23:52","pubTimestamp":1763999543,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Morgan Stanley, Merck, GencoEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter: https","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251124:nL6N3X00OY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2237443622.USD","LU1244550494.USD","LU0211331839.USD","CLSDQ","BK4547","MRK","LU2237443549.SGD","NNOX","CVNA","TSCO","H","BMY","LU0724618789.USD","IE000M9KFDE8.USD","CLSD","LU0788108826.HKD","LU0528227936.USD","HL","LU0496367417.USD","CDE","BK4115","GB00BDT5M118.USD","HUM","ALHC","IE00BMPRXN33.USD","LU1032466523.USD","KSS","PANW","GNK","GDOT","OOMA","ELV","MS","FUN","VG","LU0306807586.USD","IVVD","NRSN","BIIB","EXAS","LU0278409577.USD","BLFY","NPCE"],"gpt_icon":1},{"id":"2585495562","title":"BUZZ-NeuroSense rises after U.S. FDA clears late-stage ALS drug trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2585495562","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585495562?lang=en_us&edition=fundamental","pubTime":"2025-11-24 23:29","pubTimestamp":1763998157,"startTime":"0","endTime":"0","summary":"BUZZ-NeuroSense rises after U.S. FDA clears late-stage ALS drug trial** Shares of drug developer NeuroSense Therapeutics' NRSN.O rise 9% to $1.20 during early trading** Co says has received clearance from the U.S. FDA to begin late-stage clinical trial of its experimental drug, PrimeC, for amyotrophic lateral sclerosis or ALS** Amyotrophic lateral sclerosis is a fatal neurodegenerative disease** The late-stage trial will enroll 300 patients in U.S. and EU; aims to confirm prior mid-stage results - NRSN** Co's PrimeC combines two approved drugs to slow ALS progression by targeting inflammation and RNA regulation, co says** Including session's move, stock down ~1.7% YTD   ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251124:nL4N3X00VT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NRSN"],"gpt_icon":0},{"id":"2585493389","title":"Neurosense Receives FDA Clearance to Initiate Pivotal Phase 3 Trial for Primec in ALS","url":"https://stock-news.laohu8.com/highlight/detail?id=2585493389","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585493389?lang=en_us&edition=fundamental","pubTime":"2025-11-24 22:56","pubTimestamp":1763996215,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251124:nFWN3X00F0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","NRSN"],"gpt_icon":0},{"id":"2585493380","title":"FDA Clears NeuroSense Therapeutics to Launch Phase 3 Trial of PrimeC for ALS","url":"https://stock-news.laohu8.com/highlight/detail?id=2585493380","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585493380?lang=en_us&edition=fundamental","pubTime":"2025-11-24 22:56","pubTimestamp":1763996208,"startTime":"0","endTime":"0","summary":"NeuroSense Therapeutics Ltd. has received clearance from the U.S. Food and Drug Administration  to initiate a pivotal Phase 3 clinical trial for its lead drug candidate, PrimeC, for the treatment of amyotrophic lateral sclerosis . The global Phase 3 trial, named PARAGON, will enroll 300 participants in the U.S. and EU, and will build on promising results from NeuroSense's previous Phase 2b PARADIGM trial. This regulatory approval enables NeuroSense to proceed with the trial, with patient enrollment expected to begin in the coming months. No other organizations are mentioned as recipients of this regulatory approval.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Neurosense Therapeutics Ltd. published the original content used to genera","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251124:nNDL9JmTj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NRSN"],"gpt_icon":0},{"id":"2585117609","title":"NeuroSense Therapeutics Shareholders to Vote on Granting Restricted Shares to Non-Management Directors at Upcoming Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2585117609","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585117609?lang=en_us&edition=fundamental","pubTime":"2025-11-21 19:37","pubTimestamp":1763725044,"startTime":"0","endTime":"0","summary":"NeuroSense Therapeutics Ltd. has scheduled a Special General Meeting of Shareholders for December 30, 2025. At the meeting, shareholders will vote on a proposal to approve the grant of restricted shares to the company's non-management directors for 2024. The Board of Directors and the Compensation Committee recommend voting in favor of this proposal.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Neurosense Therapeutics Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 21, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251121:nNDL58BWPQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NRSN"],"gpt_icon":0},{"id":"2580219780","title":"NeuroSense Therapeutics to Host Investor Update Webinar","url":"https://stock-news.laohu8.com/highlight/detail?id=2580219780","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580219780?lang=en_us&edition=fundamental","pubTime":"2025-11-03 22:15","pubTimestamp":1762179323,"startTime":"0","endTime":"0","summary":"NeuroSense Therapeutics Ltd. will host an investor update webinar on December 8, 2025. The company will provide updates on the initiation of its Phase 3 PARAGON study for ALS, submission of a Notice of Compliance with conditions in Canada, the status of a binding term sheet from December 2024, and the RoAD Phase 2 program for Alzheimer's disease.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Neurosense Therapeutics Ltd. published the original content used to generate this news brief via PR Newswire  on November 03, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251103:nNDL3pkCND:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NRSN","BK4139"],"gpt_icon":0},{"id":"2579105992","title":"NeuroSense files to sell 333K ordinary shares for holders","url":"https://stock-news.laohu8.com/highlight/detail?id=2579105992","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579105992?lang=en_us&edition=fundamental","pubTime":"2025-10-29 04:36","pubTimestamp":1761683803,"startTime":"0","endTime":"0","summary":"16:31 EDT NeuroSense (NRSN) files to sell 333K ordinary shares for holders Published first on TheFly – the ultimate source for real-time, market-mo...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/neurosense-files-to-sell-333k-ordinary-shares-for-holders-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/neurosense-files-to-sell-333k-ordinary-shares-for-holders-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","NRSN"],"gpt_icon":0},{"id":"2575215038","title":"Neurosense Therapeutics Ltd : Noble Capital Initiates Coverage With Outperform Rating; Target Price $9","url":"https://stock-news.laohu8.com/highlight/detail?id=2575215038","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575215038?lang=en_us&edition=fundamental","pubTime":"2025-10-14 21:30","pubTimestamp":1760448603,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251014:nFWN3VV21V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","NRSN"],"gpt_icon":0},{"id":"2573867012","title":"NeuroSense announces ‘positive’ results from Phase-2b PARADIGM study","url":"https://stock-news.laohu8.com/highlight/detail?id=2573867012","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573867012?lang=en_us&edition=fundamental","pubTime":"2025-10-06 21:10","pubTimestamp":1759756233,"startTime":"0","endTime":"0","summary":"NeuroSense (NRSN) Therapeutics announced new positive findings based on plasma samples from its Phase-2b PARADIGM study. These results indicate tha...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/neurosense-announces-positive-results-from-phase-2b-paradigm-study-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/neurosense-announces-positive-results-from-phase-2b-paradigm-study-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NRSN","BK4139"],"gpt_icon":0},{"id":"2573667086","title":"Neurosense Therapeutics Ltd -Primec Produces Statistically Significant Reductions in Alzheimer’s Disease Biomarkers","url":"https://stock-news.laohu8.com/highlight/detail?id=2573667086","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573667086?lang=en_us&edition=fundamental","pubTime":"2025-10-06 21:09","pubTimestamp":1759756181,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251006:nFWN3VN1CP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","NRSN"],"gpt_icon":0},{"id":"2573772086","title":"NeuroSense Therapeutics Announces Positive Phase 2b Results for PrimeC, Showing Significant Reduction in Alzheimer’s Disease Biomarkers","url":"https://stock-news.laohu8.com/highlight/detail?id=2573772086","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573772086?lang=en_us&edition=fundamental","pubTime":"2025-10-06 21:00","pubTimestamp":1759755657,"startTime":"0","endTime":"0","summary":"NeuroSense Therapeutics Announces Positive Phase 2b Results for PrimeC, Showing Significant Reduction in Alzheimer's Disease Biomarkers. NeuroSense Therapeutics Ltd.  has announced new findings from its Phase-2b PARADIGM clinical study evaluating PrimeC in Alzheimer's disease. According to the company, analysis of plasma samples demonstrated that PrimeC significantly reduced several microRNAs associated with Alzheimer's disease pathology, including miR-146a-5p, miR-21-5p, miR-let-7a-5p, and miR-let-7e-5p, as measured by change from baseline. These microRNAs are linked to neuroinflammation, amyloid and tau pathology, and synaptic dysfunction. No significant changes in these biomarkers were observed in the placebo group. The results have already been presented by NeuroSense and are expected to inform the design of future Alzheimer's disease studies, while the company continues to advance PrimeC's Phase 3 readiness program in ALS.Disclaimer: This news brief was created by Public Technolog","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251006:nNDL50KBy6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NRSN","BK4139"],"gpt_icon":0},{"id":"2570182450","title":"NeuroSense Therapeutics Ltd. Held Annual General Meeting of Shareholders","url":"https://stock-news.laohu8.com/highlight/detail?id=2570182450","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2570182450?lang=en_us&edition=fundamental","pubTime":"2025-09-25 21:24","pubTimestamp":1758806662,"startTime":"0","endTime":"0","summary":"NeuroSense Therapeutics Ltd. held its Annual General Meeting of Shareholders on September 25, 2025. At the meeting, all proposed resolutions outlined in the company's Notice and Proxy Statement were approved by shareholders.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Neurosense Therapeutics Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on September 25, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250925:nNDL7BBDzd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NRSN","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":2,"totalSize":40,"code":"91000000","status":"200"}]}}